Benzinga
11 Aug 2026, 06:06 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Analysts expect Cardinal Health to report Q4 earnings of $2.42 per share and revenue of $65.11 billion, both increasing year-over-year. — Positive growth expectations for a major healthcare distributor generally support a higher stock valuation ahead of earnings.
+0.40Cardinal Health is acquiring the diabetes health business of Adapthealth and Strive Medical for $360 million in cash. — Strategic acquisitions to expand market share in specialized health sectors are typically viewed as growth-positive.
+0.30Analysts from UBS, TD Cowen, and Mizuho have recently maintained Buy/Outperform ratings and raised their price targets for CAH. — Upward price target revisions from multiple firms signal institutional confidence in the stock's trajectory.
+0.20Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
Positive analyst revisions, price target increases, and expected growth in earnings and revenue.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Benzinga
1h ago
